Barbara Klencke
Login to view DISC.Dr. Barbara Klencke is an experienced biotech executive and board director for several oncology companies, including ALX Oncology, Xencor, and TScan Therapeutics. A physician with an M. D. from UC Davis, she has a significant track record in clinical development, notably contributing to the FDA approval of momelotimib (Ojjaara) while at Sierra Oncology.
Barbara is a champion for female leadership in the biotechnology and pharmaceutical sectors. She actively supports and promotes the growth of professional networks for her colleagues, such as the CMO Sisterhood, to foster a strong community for senior women physician leaders in the industry.
She has played a major role in the successful development and approval of multiple first-in-class oncology therapies throughout her career.
Read the full overview →How Barbara shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Barbara cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.